Business Description
Nephros Inc
NAICS : 339112
SIC : 3841
ISIN : US6406714005
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.95 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -1.42 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -13.9 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 34.4 | |||||
3-Year EPS without NRI Growth Rate | 35 | |||||
3-Year Book Growth Rate | -14.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.72 | |||||
9-Day RSI | 33.66 | |||||
14-Day RSI | 33.41 | |||||
6-1 Month Momentum % | -18.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.06 | |||||
Quick Ratio | 2.62 | |||||
Cash Ratio | 1.58 | |||||
Days Inventory | 166.52 | |||||
Days Sales Outstanding | 41.94 | |||||
Days Payable | 56.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | -4.04 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.38 | |||||
Operating Margin % | -9.94 | |||||
Net Margin % | -9.4 | |||||
FCF Margin % | -6.06 | |||||
ROE % | -15.5 | |||||
ROA % | -11.62 | |||||
ROIC % | -23.77 | |||||
ROC (Joel Greenblatt) % | -30.36 | |||||
ROCE % | -13.84 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 151.11 | |||||
PS Ratio | 1.1 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 2.3 | |||||
EV-to-EBIT | -10.58 | |||||
EV-to-EBITDA | -12.25 | |||||
EV-to-Revenue | 0.99 | |||||
EV-to-FCF | -16.14 | |||||
Price-to-Median-PS-Value | 0.17 | |||||
Price-to-Net-Current-Asset-Value | 3.12 | |||||
Earnings Yield (Greenblatt) % | -9.45 | |||||
FCF Yield % | -5.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nephros Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 12.751 | ||
EPS (TTM) (€) | -0.12 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 33.41 | ||
14-Day ATR (€) | 0.034231 | ||
20-Day SMA (€) | 1.413 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 1.31 - 3.49 | ||
Shares Outstanding (Mil) | 10.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nephros Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nephros Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nephros Inc Frequently Asked Questions
What is Nephros Inc(FRA:NPJP)'s stock price today?
When is next earnings date of Nephros Inc(FRA:NPJP)?
Does Nephros Inc(FRA:NPJP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |